“Phototherapy is a powerful, noninvasive approach for cancer treatment, with several agents currently in clinical use.
…we developed a phototherapy agent that combines a functional ligand and a near infrared phthalocyanine dye. Our target is type 2 cannabinoid receptor (CB2R), considered an attractive therapeutic target for phototherapy given it is overexpressed by many types of cancers that are located at a surface or can be reached by an endoscope.
Overall, this opens up the opportunity for development of an alternative treatment option for CB2R-positive cancers.”